Literature DB >> 8404241

Drug and placebo side effects in methylphenidate-placebo trial for attention deficit hyperactivity disorder.

S Fine1, C Johnston.   

Abstract

In a double-blind methylphenidate placebo trial for children with Attention Deficit Hyperactivity Disorder (ADHD), side effects were reported on both placebo and methylphenidate (MPH), and many side effects were similar to the symptoms of ADHD. We suggest that parents and teachers may mistake the symptoms of ADHD for side effects of MPH, and this misconstrual may contribute to the poor acceptance of and compliance with taking MPH.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8404241     DOI： 10.1007/bf02353715

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN： 0009-398X


  5 in total

1.  A survey of medication treatment for hyperactive/inattentive students.

Authors:  D J Safer; J M Krager
Journal:  JAMA       Date:  1988-10-21       Impact factor: 56.272

2.  Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation.

Authors:  R A Barkley; M B McMurray; C S Edelbrock; K Robbins
Journal:  Pediatrics       Date:  1990-08       Impact factor: 7.124

3.  Normative data on revised Conners Parent and Teacher Rating Scales.

Authors:  C H Goyette; C K Conners; R F Ulrich
Journal:  J Abnorm Child Psychol       Date:  1978-06

4.  Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: acceptability, satisfaction, and compliance.

Authors:  C Johnston; S Fine
Journal:  J Pediatr Psychol       Date:  1993-12

5.  A change of mind: the Conners abbreviated rating scales reconsidered.

Authors:  R K Ullmann; E K Sleator; R L Sprague
Journal:  J Abnorm Child Psychol       Date:  1985-12
  5 in total
  7 in total

1.  Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial.

Authors:  Heather M Conklin; Joanne Lawford; Bruce W Jasper; E Brannon Morris; Scott C Howard; Susan W Ogg; Shengjie Wu; Xiaoping Xiong; Raja B Khan
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

Review 2.  Safety issues in the use of methylphenidate. An American perspective.

Authors:  M D Rappley
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

Review 3.  [Pharmacological treatment in adults with attention deficit hyperactivity disorder].

Authors:  J Frölich; G Lehmkuhl
Journal:  Nervenarzt       Date:  2004-11       Impact factor: 1.214

4.  Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD.

Authors:  James Lee; Natalie Grizenko; Venkataramana Bhat; Sarojini Sengupta; Anna Polotskaia; Ridha Joober
Journal:  BMC Psychiatry       Date:  2011-04-21       Impact factor: 3.630

Review 5.  The nocebo effect as a source of bias in the assessment of treatment effects.

Authors:  Karolina Wartolowska
Journal:  F1000Res       Date:  2019-01-03

6.  Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial.

Authors:  T Michnevich; Y Pan; A Hendi; K Oechsle; A Stein; Y Nestoriuc
Journal:  BMC Cancer       Date:  2022-09-23       Impact factor: 4.638

Review 7.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.